ssris and other antidepressant use during pregnancy and potential neonatal adverse effects impact of a public health advisory and subsequent reports in the news media选择性血清再吸收抑制剂和其他抗抑郁药物使用的孕期和新生儿不良反应的潜在影响公众健康咨询和随后的新闻媒体的报道.pdfVIP

BMC Pregnancy and Childbirth BioMed Central Research article Open Access SSRIS and other antidepressant use during pregnancy and potential neonatal adverse effects: Impact of a public health advisory and subsequent reports in the news media 1 2 3 1 1 A Einarson* , AK Schachtschneider , R Halil , E Bollano and G Koren 1 2 Address: The Motherisk Program, The Hospital for Sick Children, Toronto, Canada, Department of Pharmacoepidemiology Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands and 3The Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada Email: A Einarson* - einarson@sickkids.ca; AK Schachtschneider - a.k.schachtschneider@students.uu.nl; R Halil - roland.halil@utoronto.ca; E Bollano - enkabollano@; G Koren - gkoren@sickkids.ca * Corresponding author Published: 20 May 2005 Received: 11 March 2005 Accepted: 20 May 2005 BMC Pregnancy and Childbirth 2005, 5:11 doi:10.1186/1471-2393-5-11 This article is available from: /1471-2393/5/11 © 2005 A et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: On Aug 9th 2004 Health Canada released an advisory, which followe